Ticker > Company >

Zenlabs Ethica share price

Zenlabs Ethica Ltd.

BSE: 530697 SECTOR: Trading  10.18 K   6   0

26.99
-1.53 (-5.36%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 29.9

Today's Low

₹ 25.5

52 Week High

₹ 44.29

52 Week Low

₹ 27.33

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

17.57 Cr.

Enterprise Value

27.65 Cr.

No. of Shares

0.65 Cr.

P/E

71.72

P/B

1.67

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  16.21

CASH

1.8 Cr.

DEBT

11.88 Cr.

Promoter Holding

52.96 %

EPS (TTM)

₹  0.38

Sales Growth

-12.19%

ROE

2.62 %

ROCE

5.96%

Profit Growth

-36.09 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-12.19%
3 Year-9.37%
5 Year-3.02%

Profit Growth

1 Year-36.09%
3 Year-29.92%
5 Year18.24%

ROE%

1 Year2.62%
3 Year4%
5 Year6.07%

ROCE %

1 Year5.96%
3 Year8.07%
5 Year10.84%

Debt/Equity

1.1393

Price to Cash Flow

4.59

Interest Cover Ratio

1.4623

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2025 52.96 0.00
Jun 2025 52.96 0.00
Mar 2025 52.96 0.00
Dec 2024 52.96 0.00
Sep 2024 52.96 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has a high promoter holding of 52.96%.

 Limitations

  • The company has shown a poor profit growth of -29.9183599629764% for the Past 3 years.
  • The company has shown a poor revenue growth of -9.37437070192769% for the Past 3 years.
  • Company has a poor ROE of 4.00316666666667% over the past 3 years.
  • The company has a low EBITDA margin of 3.99852128166058% over the past 5 years.
  • The company is trading at a high PE of 71.72.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Net Sales 13.35 12.72 12.99 11.48 12.43
Total Expenditure 12.73 12.04 12.33 10.94 11.99
Operating Profit 0.62 0.68 0.66 0.54 0.45
Other Income 0 0 0.04 0 0.06
Interest 0.23 0.24 0.23 0.21 0.19
Depreciation 0.31 0.32 0.32 0.29 0.24
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.08 0.13 0.16 0.05 0.08
Tax 0.02 0.04 0.07 0.01 0.04
Profit After Tax 0.05 0.08 0.09 0.03 0.04
Adjusted EPS (Rs) 0.08 0.13 0.14 0.05 0.06

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 56.64 69.09 66.89 58.56 51.42
Total Expenditure 54.9 66.69 63.98 56.15 48.85
Operating Profit 1.74 2.4 2.91 2.41 2.57
Other Income 0.12 0.09 0.13 0.3 0.05
Interest 0.29 0.37 0.53 0.83 0.93
Depreciation 0.71 0.89 1.25 1.29 1.26
Exceptional Items 0 0 -0.58 0 0
Profit Before Tax 0.86 1.22 0.67 0.58 0.43
Tax 0.09 0.44 0.19 0.16 0.16
Net Profit 0.77 0.78 0.49 0.42 0.27
Adjusted EPS (Rs.) 1.18 1.2 0.75 0.65 0.41

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 6.51 6.51 6.51 6.51 6.51
Total Reserves 2.05 2.82 3.19 3.61 3.92
Borrowings 0.23 0.17 1.11 0.78 0.47
Other N/C liabilities 1.5 2.96 2.99 2.06 1.37
Current liabilities 21.45 25.2 29.45 27.02 28.12
Total Liabilities 31.75 37.66 43.26 39.98 40.38
Assets
Net Block 3.51 3.53 5.03 3.7 2.29
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.7 0.7 0.7 0.7 0.7
Loans & Advances 0.05 0.03 0.04 0.04 0.04
Other N/C Assets 0 0 0 0 0
Current Assets 27.49 33.4 37.5 35.55 37.35
Total Assets 31.75 37.66 43.26 39.98 40.38
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 0.86 1.22 0.67 0.58 0.43
Adjustment 0.92 1.18 2.28 2.11 2.28
Changes in Assets & Liabilities -10.1 -2.66 -1.17 -11.62 1.34
Tax Paid -0.09 -0.12 -0.27 -0.13 -0.21
Operating Cash Flow -8.41 -0.38 1.52 -9.06 3.83
Investing Cash Flow 0.15 0 -1.47 0.11 0.14
Financing Cash Flow -0.52 0.31 0.06 8.24 -3.08
Net Cash Flow -8.78 -0.07 0.11 -0.71 0.88

Corporate Actions

Investors Details

PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
promoters 52.96 52.96 52.96 52.96 52.96
harjinder kaur 0.02 0.02 0.02 0.02 0.02
himjyoti 0.02 0.02 0.02 0.02 0.02
preet remedies limited 26.58 26.58 26.58 26.58 26.58
sanjay dhir 13.18 13.18 13.18 13.18 13.18
sanjeev kumar singal 13.17 13.17 13.17 13.17 13.17
PARTICULARS Sep 2024% Dec 2024% Mar 2025% Jun 2025% Sep 2025%
investors 47.04 47.04 47.04 47.04 47.04
b s mallikarjuna 2.17 2.18 2.19 2.14 2.14
bhasakarrai kanyalal bhat... 1.86 1.86 1.86 1.86 1.86
hitesh popatlal oswal 6.79 6.79 6.79 6.79 6.79
investor education and pr... - - - 2.48 2.48
shyama goyal 1.00 1.00 1.19 1.22 1.26

Annual Reports

Title Link
Title Link
Annual Report 2022
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Zenlabs Ethica - Quaterly Results 9 Nov, 12:00 AM Zenlabs Ethica - Quaterly Results 8 Aug, 3:20 PM Zenlabs Ethica - Quaterly Results 8 Aug, 3:20 PM Zenlabs Ethica - Quaterly Results 8 Aug, 3:20 PM Zenlabs Ethica informs about press release 13 May, 12:11 PM Zenlabs Ethica - Quaterly Results 12 May, 4:19 PM Zenlabs Ethica - Quaterly Results 12 May, 4:19 PM Zenlabs Ethica - Quaterly Results 12 May, 4:19 PM Zenlabs Ethica - Quaterly Results 7 Feb, 3:52 PM Zenlabs Ethica - Quaterly Results 7 Feb, 3:52 PM Zenlabs Ethica - Quaterly Results 7 Feb, 3:52 PM Zenlabs Ethica - Quaterly Results 12 Nov, 2:22 PM Zenlabs Ethica - Quaterly Results 12 Nov, 2:22 PM Zenlabs Ethica - Quaterly Results 7 Aug, 2:51 PM Zenlabs Ethica - Quaterly Results 7 Aug, 2:51 PM Zenlabs Ethica - Quaterly Results 7 Aug, 2:51 PM Zenlabs Ethica informs about loss of share certificates 20 Jun, 1:21 PM Zenlabs Ethica - Quaterly Results 20 May, 3:44 PM Zenlabs Ethica - Quaterly Results 20 May, 3:44 PM Zenlabs Ethica - Quaterly Results 20 May, 3:44 PM Zenlabs Ethica informs about details of loss of certificate 28 Feb, 4:59 PM Zenlabs Ethica - Quaterly Results 29 Jan, 1:14 PM Zenlabs Ethica - Quaterly Results 29 Jan, 1:14 PM Zenlabs Ethica - Quaterly Results 29 Jan, 1:14 PM Zenlabs Ethica informs about press release 7 Nov, 3:02 PM Zenlabs Ethica - Quaterly Results 6 Nov, 3:46 PM Zenlabs Ethica - Quaterly Results 6 Nov, 3:46 PM Zenlabs Ethica - Quaterly Results 6 Nov, 3:46 PM Zenlabs Ethica - Quaterly Results 28 Jul, 4:46 PM Zenlabs Ethica - Quaterly Results 28 Jul, 4:46 PM Zenlabs Ethica - Quaterly Results 28 Jul, 4:46 PM Zenlabs Ethica - Quaterly Results 24 May, 2:11 PM Zenlabs Ethica - Quaterly Results 24 May, 2:11 PM Zenlabs Ethica - Quaterly Results 24 May, 2:11 PM Zenlabs Ethica - Quaterly Results 9 Feb, 3:44 PM Zenlabs Ethica - Quaterly Results 9 Feb, 3:44 PM Zenlabs Ethica - Quaterly Results 9 Feb, 3:44 PM Zenlabs Ethica - Quaterly Results 18 Oct, 3:43 PM Zenlabs Ethica - Quaterly Results 18 Oct, 3:43 PM Zenlabs Ethica - Quaterly Results 18 Oct, 3:43 PM Zenlabs Ethica - Quaterly Results 20 Jul, 4:23 PM Zenlabs Ethica - Quaterly Results 20 Jul, 4:23 PM Zenlabs Ethica - Quaterly Results 20 Jul, 4:23 PM Zenlabs Ethica informs about appointment of CS cum CO 30 Jun, 5:22 PM Zenlabs Ethica informs about closure of trading window 30 Jun, 1:50 PM Zenlabs Ethica informs about disclosure 21 Jun, 9:51 AM Zenlabs Ethica informs about newspaper publication 11 May, 4:36 PM Zenlabs Ethica - Quaterly Results 10 May, 6:53 PM Zenlabs Ethica - Quaterly Results 10 May, 6:53 PM Zenlabs Ethica informs about clarification on price movement 10 Jan, 4:31 PM

Zenlabs Ethica Stock Price Analysis and Quick Research Report. Is Zenlabs Ethica an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Zenlabs Ethica. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Zenlabs Ethica has a PE ratio of 71.7246877491363 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Zenlabs Ethica has ROA of 0.6699% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Zenlabs Ethica has a Current ratio of 1.328.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Zenlabs Ethica has a ROE of 2.6202%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Zenlabs Ethica has a Debt to Equity ratio of 1.1393 which means that the company has low proportion of debt in its capital.

  • Sales growth: Zenlabs Ethica has reported revenue growth of -12.193% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Zenlabs Ethica for the current financial year is 4.99567310029656%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Zenlabs Ethica is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Zenlabs Ethica is Rs 0.3763. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Zenlabs Ethica in Ticker for free. Also, one can get the intrinsic value of Zenlabs Ethica by using Valuation Calculators, which are available with a Finology ONE subscription. 

Zenlabs Ethica FAQs

Q1. What is Zenlabs Ethica share price today?
Ans: The current share price of Zenlabs Ethica is Rs 26.99.

Q2. What is the market capitalisation of Zenlabs Ethica?
Ans: Zenlabs Ethica has a market capitalisation of Rs 17.570530485 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Zenlabs Ethica?
Ans: The PE ratio of Zenlabs Ethica is 71.7246877491363 and the P/B ratio of Zenlabs Ethica is 1.66545310938059, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Zenlabs Ethica share?
Ans: The 52-week high share price of Zenlabs Ethica is Rs 44.29, and the 52-week low share price of Zenlabs Ethica is Rs 27.33.

Q5. Does Zenlabs Ethica pay dividends?
Ans: Currently, Zenlabs Ethica does not pay dividends. Dividend yield of Zenlabs Ethica is around 0%.

Q6. What are the face value and book value of Zenlabs Ethica shares?
Ans: The face value of Zenlabs Ethica shares is Rs 10, while the book value per share of Zenlabs Ethica is around Rs 16.2058. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Zenlabs Ethica?
Ans: Zenlabs Ethica has a total debt of Rs 11.8773 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Zenlabs Ethica?
Ans: The ROE of Zenlabs Ethica is 2.6202% and ROCE of Zenlabs Ethica is 5.96%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Zenlabs Ethica a good buy for the long term?
Ans: The Zenlabs Ethica long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Zenlabs Ethica undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Zenlabs Ethica appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Zenlabs Ethica’s financials?
Ans: You can review Zenlabs Ethica’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Zenlabs Ethica
X